Seastar Medical Holding Corporation has resumed sales of its common stock under an At the Market Offering Agreement with H.C. Wainwright & Co., LLC as the sales agent. The company had previously suspended sales on July 10, 2025, after selling an aggregate of $6.8 million in shares. The resumed offering will allow sales up to an aggregate offering price of $2,166,305. The exact number of shares and their price are not determinable at this time.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-105906), on August 08, 2025, and is solely responsible for the information contained therein.